Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche's Avastin Fails to Help Early-Stage Colon Cancer Patients in Study
Bloomberg
Monday, September 20, 2010 - 11:33am
tags:
colon cancer, Roche, Genentech
Keryx Remains a Focused, Well-Funded Bio-Pharma Play
Seeking Alpha
Monday, September 20, 2010 - 11:29am
tags:
Keryx, Zerenex, Japan
J&J on the Hunt for China M&A
Seeking Alpha
Monday, September 20, 2010 - 11:02am
tags:
M&A, JNJ, China, Xian-Janssen, Hutchison MediPharma
Johnson & Johnson's troubled times
CNN Money
Monday, September 20, 2010 - 11:01am
tags:
JNJ, recalls
Spiriva as good as Serevent in asthma study
Yahoo/AP
Monday, September 20, 2010 - 11:00am
tags:
Serevent, Spiriva, GSK, asthma, Teva Pharmaceuticals, Boehringer Ingelheim
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Seeking Alpha
Monday, September 20, 2010 - 10:58am
tags:
blood thinners, AstraZeneca, Bristol-Myers Squibb, Bayer, Eisai, Pfizer, Sanofi, Brilinta, Portola Pharmaceuticals, Boehringer Ingelheim
Penwest Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry With the Highest Operating Margin (PPCO, POZN, QCOR, VPHM, KV.A)
Smartrend
Saturday, September 18, 2010 - 12:09pm
tags:
Penwest, Questcor Pharmaceuticals, ViroPharma, KV Pharmaceutical, Pozen
SuperGen - an Underappreciated Biotech with Cash + FCF
Gurufocus
Saturday, September 18, 2010 - 12:06pm
tags:
Supergen, investors
Sanofiboard may be key to Genzyme deal
Calgary Herald, Canada
Saturday, September 18, 2010 - 11:35am
tags:
Sanofi, Genzyme, M&A
FDA reviewing safety of Actos diabetes drug
MSNBC
Saturday, September 18, 2010 - 11:28am
tags:
Actos, diabetes, Takeda
F.D.A. Postpones Rule on Breast Cancer Drug
NY Times
Saturday, September 18, 2010 - 11:27am
tags:
Avastin, Genentech
More Upside for Bristol-Myers Squibb ?
Traders Huddle
Saturday, September 18, 2010 - 11:25am
tags:
Bristol-Myers Squibb
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Saturday, September 18, 2010 - 11:07am
tags:
Ista, Alexza, Biodel, Alkermes, Vivus
Johnson & Johnson: More Buffett-Like Every Day
Motley Fool
Saturday, September 18, 2010 - 11:04am
tags:
JNJ, Crucell
Big Pharma Awakes From Long Slumber
Yahoo/Investor's Business Daily
Saturday, September 18, 2010 - 11:03am
tags:
Big Pharma
House probing possible second secret recall by J&J
Yahoo/AP
Saturday, September 18, 2010 - 11:02am
tags:
JNJ, recalls
FDA Pushes Out Brilinta Action Date
Yahoo/Zacks
Saturday, September 18, 2010 - 11:01am
tags:
AstraZeneca, Brilinta, acute coronary syndrome, Plavix, Bristol-Myers Squibb
Thanks for Nothing, Fen-Phen
Motley Fool
Saturday, September 18, 2010 - 10:58am
tags:
Abbott Laboratories, Meridia, Sanofi, Acomplia, Arena Pharmaceuticals
FDA panel urges wider use for Alkermes drug
Reuters
Friday, September 17, 2010 - 11:55am
tags:
FDA, advisory panels, Alkermes, addiction, Vivitrol
Sanofi board heavyweights may be key to Genzyme deal
Yahoo/Reuters
Friday, September 17, 2010 - 11:54am
tags:
M&A, Genzyme, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.